Higher PA1-nuc HS levels were indicated in the groups of patients with postmenopausal group (P = 0.0097), lower tumor size (P = 0.0025), negative Ki67 (P = 0.02), and positive AR (P = 0.049) and positive ERβ (P = 0.0020). Here, ESR2 is linked to neoplasm.